Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

UBM safe to hold, says Berenberg, as Informa bid looks certain to be approved

Although Berenberg believes UBM is worth a lot less than what Informa is paying for it, the high probability of the bid being waved through means there is no longer any point in sticking with its 675p price target
Asian models
Informa will likely have to address increasing headwinds in the fashion segment

With Informa’s bid for UBM likely to be approved by both sets of shareholders, there is no longer much risk to holding the latter.

That’s the view of German bank Berenberg, which has abandoned its ‘sell; recommendation on business-to-business events organiser UBM PLC (LON:UBM) and moved it to ‘hold’.

Taking on inherent risks 

The price target has been whacked up from 675p to 930p, which is roughly the level of the offer terms, with Berenberg stating that the bid from Informa PLC (LON:INF) means the publishing group is taking on the risks inherent in the UBM business, especially the reliance on the fashion sector.

“In the short-term, Informa will likely have to address increasing headwinds in the fashion segment (c20% of UBM’s FY17 Events revenue). In the absence of new launches in Japan, this fell by 6.9%, and the trend is expected to be similar in FY18 – we think there is a risk that Informa will have to cut prices here as it addresses the pressures on the target attendee base of physical fashion retailers,” Berenberg declared.

On the margin front, the recent upward trajectory may not be easy to continue or even maintain, Berenberg believes, and notes that UBM’s management flagged the 2017 benefit from FX tailwinds and shifting the cost to biennial events, both of which reverse in 2018.

How sustainable is the top-line growth

Although Informa is paying a big premium for UBM, in Berenberg’s view, the combined group will have some “scarcity value”.

“The enlarged company will have market cap of near £9bn and deliver 4% organic growth, yet trades at just 13x 2019 earnings. This combination has significant scarcity value, being a c20% discount to RELX still despite its own de-rating, and we think there is substantial scope for a re-rating,” Berenberg said, as it reiterated its ‘buy’ rating on Informa.

The price target moves from 825p to 800p, largely reflecting recent currency fluctuations and higher depreciation levels.

For the combined entity, the key question is how sustainable is the top-line growth.

“In the short-term, the recent trade body survey showed growth expectations around the world improving into H2 2018. Fundamentally, greater scale and use of technology is unlikely to drive upside to forecasts – otherwise it would likely have been seen already at RELX – but it should contribute to greater resilience of growth as customer lists & operational best practice are shared,” Berenberg said.

Shares in Informa rose 0.8% to 716.4p on Thursday morning.

View full INF profile View Profile

Informa Group Timeline

Newswire
November 24 2017

Related Articles

mobile phone
January 22 2018
Tremor is already in profit a year ahead of expectations and is a blueprint for similar acquisitions in the future.
Bricklive
December 28 2017
Apparently, at some point in their lives every person in the UK will hold or touch a Lego brick - Parallel is building a business around the famous plastic bricks
Cello
April 16 2018
Global pharmaceutical R&D is forecast to reach $182bn by 2022 having grown at near 4% annually since 2006

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use